COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Napoleone Ferrara Awarded The Economist’s 2012 Innovation Award for Bioscience

 

November 16, 2012  |  

Napoleone Ferrara, MD, PhD, the molecular biologist credited with helping decipher how tumors grow, and with development of new treatments for both cancer and age-related macular degeneration, has been named recipient of The Economist magazine’s 2012 Innovation Award for bioscience.

Naploleon Ferrara

Napoleon Ferrara, MD, PhD

Ferrara, 56, joins the University of California, San Diego School of Medicine on December 1 as a professor of pathology and as senior deputy director for basic science at the UC San Diego Moores Cancer Center. He comes from Genentech, the San Francisco-based biotechnology company where he served as a long-time research fellow.

The Innovation prize in bioscience honors Ferrara’s work identifying the role of the human VEGF gene in promoting angiogenesis – the formation of new blood vessels that can feed tumor growth – and subsequent development of two major monoclonal antibody drugs: Bevacizumab (marketed as Avastin), which is used treat multiple forms of cancer, including breast, brain and colorectal, and ranibizumab (marketed as Lucentis), which treats wet age-related macular degeneration, a leading cause of blindness in the elderly.

“Not only did he help explain how tumors proliferate through angiogenesis,” said Scott Lippman, MD, director of the UC San Diego Moores Cancer Center. “He took this new knowledge and translated it into novel clinical treatments that benefit real patients. We’re thrilled to bring his vision, passion and commitment for truly collaborative scientific discovery and clinical progress to Moores.”

At UC San Diego Moores Cancer Center, Ferrara will continue his cancer drug development research targeting angiogenesis and oversee the center’s basic science operation.

In 2010, Ferrara received the highly regarded Lasker-DeBakey Clinical Medical Research award for his work. Winners of Lasker awards have also won Nobel Prizes, as have several Economist Innovation recipients. Previous Innovation award winners in bioscience include artificial skin inventor Robert Langer, Harald zur Hausen, the Nobel Laureate who discovered the viral cause of cervical cancer, and J. Craig Venter, a pioneer in human genome sequencing and president of the J. Craig Venter Institute in La Jolla.

Now in their 11th year, The Economist’s Innovation Awards celebrate individual innovators whose efforts have had great impact upon business and/or society. An international panel of 29 judges selected honorees in categories that include energy and the environment, computing and telecommunications, social and economic innovation and consumer products. The winners were announced at a London ceremony last night.

# # #

Media contact: Scott LaFee, 619-543-6163, slafee@ucsd.edu


Related Specialties

Cancer



Media Contact

Share This Article


Related News

1/20/2021
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
1/10/2021
University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Sciences researchers report that starting tobacco products, including e-cigarettes, before the age of 18 ...
12/23/2020
UC San Diego and Ludwig Cancer Research scientists describe how a phenomenon known as “chromothripsis” breaks up chromosomes, which then reassemble in ways that ultimately promote cancer cell growth.
12/10/2020
Bernard Thurman was referred to a personalized cancer therapy trial at Moores Cancer Center at UC San Diego Health, a collaboration with the La Jolla Institute for Immunology, the trial employs a pati ...



Follow Us